Intermittent Fasting for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether intermittent fasting can reduce depression and inflammation in people with spinal cord injuries (SCI). Participants will fast for 16 hours a day over eight weeks, with some receiving additional support, such as education and encouragement, to determine if it enhances the benefits. The trial aims to find a simple, cost-effective way to manage depression and inflammation in SCI patients. Individuals who have had a spinal cord injury for at least a year and experience mild to moderate depression might be suitable for this study. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could lead to new, accessible treatments for SCI-related depression and inflammation.
Will I have to stop taking my current medications?
The trial requires that participants have a stable dose of depression medications, so you won't need to stop those. However, if you are using anti-inflammatory or anticoagulant medications, you cannot participate in the trial.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that intermittent fasting is generally safe for most people, including those with specific health conditions like spinal cord injury (SCI). One study on fasting every other day found it was well-tolerated by people with SCI, with no serious side effects reported. Other studies in animals also suggest benefits, such as better recovery after SCI, without major safety concerns.
While the long-term effects of intermittent fasting in people with SCI remain unclear, existing studies in similar situations indicate it is safe. This trial will carefully monitor participants to ensure their health and safety. Prospective participants can be confident that the researchers prioritize their safety.12345Why are researchers excited about this trial?
Researchers are excited about using intermittent fasting for spinal cord injury because it offers a fresh approach compared to traditional treatments like physical therapy, medications, or surgery. Intermittent fasting is unique as it involves a dietary pattern that restricts eating to an 8-hour window each day, potentially providing metabolic benefits that aid in recovery. Additionally, one arm of the study combines fasting with behavioral support strategies, including coaching and self-monitoring through a smartphone app, which could enhance adherence and effectiveness. This approach is different from the typical focus on physical or pharmaceutical interventions and aims to harness the body's natural processes for potential healing and improvement.
What evidence suggests that intermittent fasting might be an effective treatment for depression in people with spinal cord injury?
Research has shown that intermittent fasting can lower inflammation and boost mood in people without spinal cord injuries. Animal studies have suggested that intermittent fasting might aid recovery after spinal cord injuries. However, its effects on depression and inflammation in people with spinal cord injuries remain unclear. This trial will compare two approaches: one group will follow an intermittent fasting protocol combined with behavioral support strategies, while another group will follow the intermittent fasting protocol without additional support. Intermittent fasting is a simple eating pattern that might be easier to maintain than strict diets, making it a potentially good long-term choice. Early findings suggest that combining fasting with support, such as encouragement and self-monitoring, might help people adhere to the routine better. More research is needed to confirm these benefits for people with spinal cord injuries.12367
Who Is on the Research Team?
David J Allison, PhD.
Principal Investigator
Lawson Research Institute
Are You a Good Fit for This Trial?
This trial is for individuals with spinal cord injury (SCI) who are also experiencing depression. Participants should be interested in trying intermittent fasting as a potential treatment. The study excludes those who cannot safely fast or have conditions that might interfere with the intervention.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo intermittent fasting for 16 hours per day for 8 weeks, with one group receiving additional behavioral support
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Behavioral Support Strategies
- Intermittent Fasting
Find a Clinic Near You
Who Is Running the Clinical Trial?
London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's
Lead Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead Sponsor
London Health Sciences Centre OR Lawson Research Institute of St. Joseph's
Lead Sponsor